TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz is biopharmaceutical research organization that pursues new diagnostics and drugs for the treatment of cancer and other severe diseases with high medical need. A focus of TRON is the development of novel platforms for individualized therapies and biomarkers, translating basic research into drug applications. TRON partners with academic institutions, biotech companies and the pharmaceutical industry, executing research with leading-edge technologies and supporting the development of innovative drugs to promote human health.


2014-09-16 HLA

Mining the genetic information of cancer cell lines for future therapy development

Mainz, September 15, 2014 – Cancer cell lines are a tremendous resource for cancer biology and therapy development. In a new research paper in the September issue of OncoImmunology, TRON scientists determined the HLA type and HLA expression of 167 cancer and 10 non-cancer cell lines frequently used for the identification of novel tumor targets and the development of cancer immunotherapies.

more Information


Vertical Smart Slide 1
TRON Seminar in Tran…
Posted 2 weeks ago

Mainz, September 18, 2014 - "Personalization of cancer therapy" with Prof. Hans Lehrach – Max Planck Institute for Molecular Genetics, Berlin

TRON Seminar in Tran…
Posted 3 weeks ago

The September 4 seminar “New preclinical test systems for an improved analysis of monoclonal antibody function" with Prof. Dr. Ulrich Kalinke Executive Director of TWINCORE, Centre for Experimental and Clinical Infection Research, has been cancelled.

TRON Seminar in Tran…
Posted 1 month ago

Mainz, August 20, 2014 - "Personalized therapies for lung cancer treatment: a paradigm shift in systematical cancer therapy" with Prof. Dr. med. Jürgen Wolf
Center for Integrated Oncology at the University Hospital Cologne and
Prof. Dr. med. Reinhard Büttner
University of Cologne/ Targos GmbH

TRON Seminar in Tran…
Posted 2 months ago

Mainz, July 10, 2014 - "Assessment of proliferative activity in breast cancer as a basis for individualized treatment decisions" with Prof. Hans-Anton Lehr – Institute of Pathology, Medizin Campus Bodensee, Friedrichshafen

TRON at Life Science…
Posted 3 months ago

Mainz, June 26, 2014– On July 4, the Institute for Molecular Biology (IMB) will host a Career Day for undergraduates, PhD students and postdocs interested in career options in the life sciences industry. As part of the career fair, TRON project manager Dr. Goran Martic will give a talk on the unique professional requirements posed by translational biopharmaceutical…